$14.23
0.876.51%
al cierre: Aug 26, 5:00 PM EST
$14.29
0.05760.4%
After hour: 7:55 PM EST
Summit Therapeutics Inc
SMMTNASDAQ
PRO
Summit Therapeutics Earnings & Forecasts
Summit Therapeutics (SMMT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Summit Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.23 | $-0.10 | $-0.08 |
| Actual | $-0.19 | $-0.15 | $-0.14 | $-0.13 |
| Surprise | +13.6% | +34.8% | -40.0% | -62.5% |
| Revenue | ||||
| Estimate | $88500 | $40850 | $56.8M | $56.9M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.28 | $-0.28 | $-0.28 |
| Revenue | ||||
| Consensus | $53640 | $3.9M | — | — |